Steve Aselage's Net Worth
Steve Aselage's net worth is estimated to be at least $3,824,819.28 as of 12/23/2024. CoreStreet's estimation of Steve Aselage's net worth is based on their sale of stock and current holding of stock.
Steve Aselage is Director at BioCryst Pharmaceuticals Inc. They have executed at least 13 trades of stock as per SEC Form 4 filings. Their most recent trade was for 2,500 units of BCRX stock on 05/24/2024. Their biggest sale was on 10/07/2021 when they sold 60,000 units of Travere Therapeutics Inc stock for $1,575,000.00. They typically trade 2 times per year.
Total value of insider buys:
- $247,744.40
Total value of insider sells:
- $3,577,074.88
Most recent insider trade:
- May 24, 2024
Steve Aselage's Insider Trading History
| BioCryst Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 24, 2024 | Director | 2,500 | $6.40 | Buy | $16,000.00 |
May 22, 2019 | Director | 3,000 | $3.57 | Buy | $10,710.00 |
March 12, 2019 | Director | 2,000 | $8.30 | Buy | $16,600.00 |
| Travere Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 11, 2022 | Director | 2,575 | $21.92 | Sell | $56,444.00 |
Nov. 16, 2021 | Director | 31,800 | $29.39 | Sell | $934,602.00 |
Nov. 5, 2021 | Director | 10,000 | $26.23 | Sell | $262,300.00 |
Oct. 7, 2021 | Director | 60,000 | $26.25 | Sell | $1,575,000.00 |
April 16, 2021 | Director | 10,000 | $26.23 | Sell | $262,300.00 |
March 17, 2021 | Director | 17,727 | $27.44 | Sell | $486,428.88 |
| Acer Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 9, 2021 | Director | 2,016 | $2.15 | Buy | $4,334.40 |
July 24, 2020 | Director | 45,000 | $3.50 | Buy | $157,500.00 |
July 3, 2019 | Director | 5,000 | $3.72 | Buy | $18,600.00 |
Dec. 14, 2017 | Director | 2,000 | $12.00 | Buy | $24,000.00 |